Showing results (21-30 of 84) with videos related to
Sort By:
Pageof 9
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|November 20, 2012
[Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases]Pu-yuan Xing, Yuan-kai Shi, Xiao-hui He, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 25, 2003
[Clinical and pathological features of 23 patients with primary lymphoma of the testis]Jian-liang Yang, Yuan-kai Shi, Xiao-hui He, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 18, 2004
[Mobilization of autologous peripheral blood stem cells with etoposide and recombinant human granulocyte colony stimulating factor in malignant tumor patients]Yuan-kai Shi, Xiao-hui He, Xiao-hong Han, et al.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|August 12, 2006
[Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial]Sheng Yang, Yuan-Kai Shi, Peng Liu, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 8, 2013
[Efficacy of erlotinib after the failure of gefitinib in patients with metastasis of non-small cell lung cancer with unknown EGFR mutation status]Yan Wang, Jun-ling Li, Zi-ping Wang, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 21, 2010
[Primary subcutaneous panniculitis-like T-cell cutaneous lymphoma: clinical presentation, treatment and prognosis]Zheng Lü, Yuan-kai Shi, Li-qiang Zhou, et al.Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|April 9, 2014
Comparison of dose-dense ABVD and standard ABVD in the treatment of early unfavorable and advanced Hodgkin's lymphoma: a retrospective analysisYun-Xia Tao, San-Yuan Sun, Su-Yi Kang, et al.Cancer Management and Research|June 14, 2019
Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trialXing-Sheng Hu, Xiao-Hong Han, Sheng Yang, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|April 18, 2013
Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung cancerPu-Yuan Xing, Jun-Ling Li, Yan Wang, et al.Chinese Medical Journal|November 20, 2012
Relationship between serum HER2 extracellular domain levels, tissue HER2 expression, and clinico-pathological parameters in early stage breast cancerLi Ma, Hong-ying Yang, Xiao-hong Han, et al.Pageof 9